Suzuki [58] et al. suggested that coupling factor 6 (CF6) contributes to vascular injury and endothelial dysfunction by suppressing the expression of CXC chemokine receptor type 4 (CXCR4), which is a crucial receptor that regulates numerous downstream endothelial effectors. The gene discussed is ATP5PF; the disease is endothelial dysfunction.